PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Feb-2026 Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates Businesswire
13-Feb-2026 Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results Businesswire
13-Feb-2026 Prothena to Report Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026 Businesswire
12-Feb-2026 Terray’s New EMMI Predict Model Sets an Industry Performance Standard – Delivering Best-In-Class Accuracy, 26x Faster Businesswire
12-Feb-2026 KD CLASS ACTION LAWSUIT FILED: Kyndryl Holdings, Inc. has been Sued for Securities Fraud after Accounting Review and CFO Exit Lead to 55% Stock Drop – BFA Law Businesswire
12-Feb-2026 Willdan Selected to Implement $112 Million in Energy Savings Projects for City of San Diego Businesswire
12-Feb-2026 Seligman Investments Launches $500M Venture Capital Arm Businesswire
12-Feb-2026 Novakand Pharma applies for Nasdaq’s approval of continued listing of the combined company post a completed reverse takeover with SVF Vaccines Novakand Pharma
12-Feb-2026 Male Plastic Surgery Advances: Dr. David Pincus Provides Specialized Approaches to Masculine Aesthetics ACCESS Newswire
12-Feb-2026 Lundbeck announces positive phase IIb top-line results with bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention Lundbeck
12-Feb-2026 RxERP and p‑Chip Corporation Announce Licensing Agreement to Enable Embedded Unit‑Level Digital Identity for DSCSA Compliance and End‑to‑End Pharmaceutical Traceability Businesswire
12-Feb-2026 Big Health Secures Funding to Accelerate Adoption of Digital Mental Health Treatments Businesswire
12-Feb-2026 Thetis Pharmaceuticals Expands Scientific Advisory Board with Leading Experts in Inflammatory Bowel Disease Businesswire
12-Feb-2026 Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer Businesswire
12-Feb-2026 GE HealthCare management to present at upcoming investor conferences Businesswire
12-Feb-2026 Baxter Reports Fourth-Quarter 2025 Results Businesswire
12-Feb-2026 NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection Businesswire
12-Feb-2026 KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting Businesswire
12-Feb-2026 Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy Businesswire
12-Feb-2026 US Foods Reports Fourth Quarter and Fiscal Year 2025 Earnings Businesswire